Mark Benton

Mark Benton currently serves as Associate Vice President and Program Leader at TScan Therapeutics since July 2025. Prior to this role, Mark Benton held multiple positions at CRISPR Therapeutics from April 2018 to June 2025, including Vice President of Program Leadership and Executive Director of Clinical Development and Pharmacology. Mark Benton has also contributed as Associate Director at Shire and AbbVie, as well as holding various scientific roles at AbbVie and Abbott Laboratories, demonstrating a strong background in clinical development, protocol authorship, and strategic oversight in oncology. Academic credentials include a Doctor of Philosophy in Neuroscience from Northwestern University and a Bachelor of Science in Biopsychology and Cognitive Science from the University of Michigan.